Project Grant R21EB035675
Award Date
12/5/24
Completion Date
11/30/27
Dollars Obligated
$174K
Federal Agency
National Institute of Biomedical Imaging and Bioenginering
Federal Grant Program
93.286
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under CFDA Program 93.286 "Discovery and Applied Research for Technological Innovations to Improve Human Health", supports the development of new radiofluorination methods and prosthetic groups to enable rapid construction of PET tracer analogs. The $122,260 award to the University of North Carolina at Chapel Hill will fund research to develop late-stage direct radiofluorination...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $505,848.59 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The Trustees of the University of Pennsylvania for the project "METAL-MEDIATED C-H RADIOFLUORINATION FOR RAPID ACCESS TO PET IMAGING AGENTS". The project aims to develop new methods for rapidly synthesizing Fluorine-18 labeled organic molecules for Positron...
This federal Project Grant award of $185,171 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) will support research to optimize polymeric chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) agents for prostate cancer detection. The research aims to synthesize and characterize CEST MRI agents with varying charge and...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $277,033 to the University of Cincinnati to develop novel approaches for introducing radiolabeled trifluoromethyl groups into PET tracers. The key objectives are to: 1) create a general strategy to transform alkyl halides into alkyl-[11C]CF3 and alkyl-[18F]CF3...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $275,773 Project Grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to Dropletpharm Inc., a for-profit company. The grant supports Dropletpharm's development of microfluidic technologies to enable low-cost and distributed manufacturing of radiopharmaceuticals for clinical and research applications. Specifically, the project aims to expand...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $1,149,264 to The University of Texas MD Anderson Cancer Center to develop a rapid, inexpensive microfluidics-based approach for dose-on-demand production of radiopharmaceuticals. The objectives are to: 1) employ a "ship-on-chip" device for isotope...
This federal Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), provides $1,706,745 to The Johns Hopkins University from August 1, 2024 through April 30, 2028. The project aims to develop novel data analysis strategies for in-vivo proton magnetic resonance spectroscopy (1H-MRS) to address the challenge of analytic variability...
This $384,863 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program supports research to develop a novel radiotracer imaging agent for detecting Gram-positive bacterial infections associated with implanted medical devices. The key products and services to be delivered include: In vitro testing of a bivalent radiotracer agent...
This $146,922 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program supports research to develop new methods for synthesizing fluorinated chemical compounds. The key objectives are to optimize electrochemical conditions to generate a diverse range of sulfonyl fluorides and aryl fluorides, which have important applications in medicinal chemistry and chemical biology. The research aims to...
This Project Grant award, valued at $1,039,146.00 and granted by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training (CFDA 93.859) program, supports the development of fluorescence lifetime imaging microscopy (FLIM) methods to study organic reactions and processes. The award aims to provide guiding principles for sustainable aqueous-organic systems, efficient methods for accessing organometallic reagents, and tactics for optimizing...